Josep Lluís Bedini

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Uric acid concentration in subjects at risk of type 2 diabetes mellitus: Relationship to components of the metabolic syndrome

Andréa Miúra da Costa, I. Igualaacute, Josep Lluís Bedini et al. · Metabolism · 2002 · 73 citations

Metabolic Syndrome, Metabolic Disorder, Diabetes +7

Elimination of Large Uremic Toxins by a Dialyzer Specifically Designed for High-Volume Convective Therapies

Francisco Maduell, Marta Arias‐Guillén, Néstor Fontseré et al. · Blood Purification · 2014 · 66 citations

Nocturnal, every-other-day, online haemodiafiltration: an effective therapeutic alternative

Francisco Maduell, Carlos Durán, Manel Vera et al. · Nephrology Dialysis Transplantation · 2011 · 50 citations · Full text

Evaluation of a new ultrasensitive assay for cardiac troponin I

Gregori Casals, Xavier Filella, Josep Lluís Bedini · Clinical Biochemistry · 2007 · 49 citations

Cardiac Muscle, Cardiomyopathy, Cardiovascular Disease +8